Renovascular Hypertension

Research output: Contribution to journalReview article

Abstract

Renovascular disease (RVD) is a major cause of secondary hypertension. Atherosclerotic renal artery stenosis is the most common type of RVD followed by fibromuscular dysplasia. It has long been recognized as the prototype of angiotensin-dependent hypertension. However, the mechanisms underlying the physiopathology of hypertensive occlusive vascular renal disease are complex and distinction between the different causes of RVD should be made. Recognition of these distinct types of RVD with different degrees of renal occlusive disease is important for management. The greatest challenge is to individualize and implement the best approach for each patient in the setting of widely different comorbidities.

Original languageEnglish (US)
JournalEndocrinology and Metabolism Clinics of North America
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Renovascular Hypertension
Fibromuscular Dysplasia
Hypertension
Kidney
Renal Artery Obstruction
Angiotensins
Vascular Diseases
Comorbidity

Keywords

  • Hypertension
  • Ischemic nephropathy
  • Renal artery stenosis
  • Renin and angiotensin
  • Renovascular disease

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Renovascular Hypertension. / Herrmann, Sandra; Textor, Stephen C.

In: Endocrinology and Metabolism Clinics of North America, 01.01.2019.

Research output: Contribution to journalReview article

@article{0e5b82773cf7479791d1a7307e0db1e4,
title = "Renovascular Hypertension",
abstract = "Renovascular disease (RVD) is a major cause of secondary hypertension. Atherosclerotic renal artery stenosis is the most common type of RVD followed by fibromuscular dysplasia. It has long been recognized as the prototype of angiotensin-dependent hypertension. However, the mechanisms underlying the physiopathology of hypertensive occlusive vascular renal disease are complex and distinction between the different causes of RVD should be made. Recognition of these distinct types of RVD with different degrees of renal occlusive disease is important for management. The greatest challenge is to individualize and implement the best approach for each patient in the setting of widely different comorbidities.",
keywords = "Hypertension, Ischemic nephropathy, Renal artery stenosis, Renin and angiotensin, Renovascular disease",
author = "Sandra Herrmann and Textor, {Stephen C}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ecl.2019.08.007",
language = "English (US)",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Renovascular Hypertension

AU - Herrmann, Sandra

AU - Textor, Stephen C

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Renovascular disease (RVD) is a major cause of secondary hypertension. Atherosclerotic renal artery stenosis is the most common type of RVD followed by fibromuscular dysplasia. It has long been recognized as the prototype of angiotensin-dependent hypertension. However, the mechanisms underlying the physiopathology of hypertensive occlusive vascular renal disease are complex and distinction between the different causes of RVD should be made. Recognition of these distinct types of RVD with different degrees of renal occlusive disease is important for management. The greatest challenge is to individualize and implement the best approach for each patient in the setting of widely different comorbidities.

AB - Renovascular disease (RVD) is a major cause of secondary hypertension. Atherosclerotic renal artery stenosis is the most common type of RVD followed by fibromuscular dysplasia. It has long been recognized as the prototype of angiotensin-dependent hypertension. However, the mechanisms underlying the physiopathology of hypertensive occlusive vascular renal disease are complex and distinction between the different causes of RVD should be made. Recognition of these distinct types of RVD with different degrees of renal occlusive disease is important for management. The greatest challenge is to individualize and implement the best approach for each patient in the setting of widely different comorbidities.

KW - Hypertension

KW - Ischemic nephropathy

KW - Renal artery stenosis

KW - Renin and angiotensin

KW - Renovascular disease

UR - http://www.scopus.com/inward/record.url?scp=85072302163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072302163&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2019.08.007

DO - 10.1016/j.ecl.2019.08.007

M3 - Review article

C2 - 31655775

AN - SCOPUS:85072302163

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

ER -